Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
- 1 January 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 67 (2) , 251-269
- https://doi.org/10.1016/j.mehy.2006.01.013
Abstract
No abstract availableKeywords
This publication has 290 references indexed in Scilit:
- Isoflavones made simple – Genistein’s agonist activity for the beta-type estrogen receptor mediates their health benefitsMedical Hypotheses, 2006
- Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosisGlia, 2005
- Coping with endothelial superoxide: potential complementarity of arginine and high-dose folateMedical Hypotheses, 2004
- Inhibitory action of minocycline on lipopolysaccharide-lnduced release of nitric oxide and prostaglandin E2 in BV2 microglial cellsArchives of Pharmacal Research, 2004
- Dietary Restriction Selectively Decreases Glucocorticoid Receptor Expression in the Hippocampus and Cerebral Cortex of RatsExperimental Neurology, 2000
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Apomorphine Up-Regulates NGF and GDNF Synthesis in Cultured Mouse AstrocytesBiochemical and Biophysical Research Communications, 2000
- Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Genistein Is Neuroprotective in Murine Models of Familial Amyotrophic Lateral Sclerosis and StrokeBiochemical and Biophysical Research Communications, 1999
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998